Itai Lieberman
Hebrew University of Jerusalem
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Itai Lieberman.
Angewandte Chemie | 2008
Itai Lieberman; Gabriel Shemer; Tcipi Fried; Edward M. Kosower; Gil Markovich
Transmission electron microscopy of the silver nanoparticles formed in the presence of the l-GSH with an Ag/ ligand concentration ratio of 50:1 showed a broad particlesize distribution in the range of 2–50 nm, with no apparent change in size distribution on addition of the bimane to the
Nano Letters | 2010
Itai Carmeli; Itai Lieberman; Leon Kraversky; Zhiyuan Fan; Alexander O. Govorov; Gil Markovich; Shachar Richter
The photosystem I (PS I) protein is one of natures most efficient light harvesting complexes and exhibits outstanding optoelectronic properties. Here we demonstrate how metal nanoparticles which act as artificial antennas can enhance the light absorption of the protein. This hybrid system shows an increase in light absorption and of circular dichroism over the entire absorption band of the protein rather than at the specific plasmon resonance wavelength of spherical metal nanoparticles (NPs). This is explained by broad-resonant and nonresonant field enhancements caused by metal NP aggregates, by the high dielectric constant of the metal, and by NP-PS I-NP antenna junctions which effectively enhance light absorption in the PS I.
ACS Chemical Neuroscience | 2011
Nir Waiskopf; Itzhak Shweky; Itai Lieberman; Uri Banin; Hermona Soreq
Butyrylcholinesterase (BChE) is the major acetylcholine hydrolyzing enzyme in peripheral mammalian systems. It can either reside in the circulation or adhere to cells and tissues and protect them from anticholinesterases, including insecticides and poisonous nerve gases. In humans, impaired cholinesterase functioning is causally involved in many pathologies, including Alzheimers and Parkinsons diseases, trait anxiety, and post stroke conditions. Recombinant cholinesterases have been developed for therapeutic use; therefore, it is important to follow their in vivo path, location, and interactions. Traditional labeling methods, such as fluorescent dyes and proteins, generally suffer from sensitivity to environmental conditions, from proximity to different molecules or special enzymes which can alter them, and from relatively fast photobleaching. In contrast, emerging development in synthesis and surface engineering of semiconductor nanocrystals enable their use to detect and follow molecules in biological milieus at high sensitivity and in real time. Therefore, we developed a platform for conjugating highly purified recombinant human BChE dimers (rhBChE) to CdSe/CdZnS quantum dots (QDs). We report the development and characterization of highly fluorescent aqueous soluble QD-rhBChE conjugates, present maintenance of hydrolytic activity, inhibitor sensitivity, and adherence to the membrane of cultured live cells of these conjugates, and outline their advantageous features for diverse biological applications.
Physica Status Solidi (a) | 2012
Yorai Amit; Adam Faust; Itai Lieberman; Lior Yedidya; Uri Banin
Archive | 2011
Uri Banin; Adiel Zimran; Itai Lieberman; Amit Sitt
Nano Letters | 2017
Ido Hadar; John P. Philbin; Yossef E. Panfil; Shany Neyshtadt; Itai Lieberman; Hagai Eshet; Sorin Lazar; Eran Rabani; Uri Banin
Journal of Physical Chemistry C | 2011
Eyal Yoskovitz; Ido Hadar; Amit Sitt; Itai Lieberman; Uri Banin
Journal of Physical Chemistry C | 2007
Simon Verleger; Natalie Rosenberg; Itai Lieberman; Shachar Richter
publisher | None
author
Archive | 2018
Itai Lieberman; Denis Glozman; Artyom Semyonov; Ehud Shaviv; Christian-Hubertus Kuechenthal; Shany Neyshtadt; Nathan Grumbach